Most people think menopause is the end of reproductive years in a woman. However, this myopic viewpoint overlooks an essential fact that strikes every woman who enters midlife. Menopause is not just about losing the ability to have children—it is a turning point that completely transforms the course of a woman’s health trajectory for the rest of her life.
Menopause typically occurs around the age of 45 to 55, when a woman stops ovulating and her ovaries significantly reduce estrogen production. What many don’t know is that estrogen goes beyond just regulating reproduction. This hormone acts as a powerful protective agent all throughout the body, safeguarding the brain, bones, and cardiovascular system. When estrogen level drops during menopause, women suddenly face increased risks for numerous age-related diseases.
The connection between menopause and cognitive health is most notable. The functions of estrogen are very important in the areas of neural development, neurotransmitter function, and protection against Alzheimer’s disease. If those protective effects go away after menopause, the consequences can be quite harmful.
Women who are past menopause have a significantly higher chance of getting Alzheimer's disease as compared to young premenopausal women and older men. On the other hand, cognitive impairment in about one third of women comes exactly during menopause, including poor verbal learning, decreased processing speed and forgetfulness. Brain imaging studies reveal decrease in both grey and white matter during this period, with the latter persisting for rest of woman’s life.
Even the common signs of menopause carry hidden dangers. Hot flashes and night sweats are not just unpleasant inconveniences – they have been associated with the increased risks of diabetes, high blood pressure, and stroke. Women who undergo severe vasomotor symptoms experience heightened stress responses and their cortisol levels go up, this in turn can impair memory as well as decrease blood flow to the brain.
The impact of estrogen loss is more evident in bone health. During puberty, estrogen helps double bone mass. Throughout adulthood, it keeps a healthy balance between bone formation and resorption, keeping bones strong and healthy.
At the onset of menopause, this protection disappears. There is a bone mineral density loss at approximately 2.5% per year during the three years around menopause - almost twenty times faster than the premenopausal rate of 0.13%. This rapid deterioration often results in osteoporosis that has devastating consequences.
The statistics are alarming: about 35% of postmenopausal women have osteoporosis, as compared to only 19% men of the same age. Women with osteoporosis have a 40% risk of a fracture during their lifetime, and hip fractures occur in postmenopausal women at ten times the rate as they occur in premenopausal women. Since hip fractures are one of the leading causes of death and disability amongst elderly women, this represents a major public health crisis.
Prior to menopause, women have a prominent shield against heart disease, with incidence rates being three times lower than those of men who are same age. However after menopause this advantage diminishes overnight.
Cardiovascular disease rates in postmenopausal women can be about 5% per year, which is sixteen times greater as compared to premenopausal levels. Women who have early menopause before the age of 35 years face two to three times higher risk of heart attack. Those who have their ovaries removed surgically before 35 see their heart attack risk increase sevenfold.
Coronary heart disease is the major cause of death among postmenopausal women. Its lifetime mortality hazard of 31% is ten times higher than that of breast cancer, which is at 3%. Nevertheless, cardiovascular disease in women receives far less attention and research funding than cancer.
Since estrogen is known for its protective properties, hormone replacement therapy (HRT) helps fight these risks. HRT might prove quite effective once it is initiated early in the menopausal transition, mainly in those women who do not have any specific risk factors e.g. a family history of breast cancer.
Studies reveal that HRT increases bone mineral density and decreases fracture risk in women with osteoporosis. When initiated within ten years of menopause, HRT reduces cardiovascular events and mortality rates considerably. Long term estrogen treatment may reduce the possibility of Alzheimer’s by roughly 5% per year.
While it affects half of the aged population, menopause receives little attention and is often not diagnosed. Women are still not proportionately represented in clinical trials especially early-phase dosing studies whereby this leads to a situation where adverse drug reactions occur twice as often in women as in men.
Current methods of diagnosis fall short, as a woman has to go through twelve months without menstruation before she can be declared menopausal - and by then it is too late for an effective intervention. Policy solutions can involve obliging insurance companies to cover costs of regular ovarian reserve testing at the age of 45 and above, which is similar to what has been the case with mammograms that reduced breast cancer mortality.
Menopause deserves the place of distinction as the major health transition which in reality it is- one that changes significantly the women‘s risk for the diseases which sooner or later will determine their health span and lifespan. It's high time we proceeded from regarding menopause only as a basis of fertility, to regarding it as a key health event it represents for every aging woman.
